Brief: Lepu Biopharma To Sell 15% Of Equity Interest Of Hangzhou Healsun Biopharma

Lepu Biopharma

29/09/2023 01:24

Sept 29 (Reuters) - Lepu Biopharma Co Ltd  2157.HK :
    * DISPOSAL OF 15% EQUITY INTEREST IN AN ASSOCIATE
    * CO TO SELL 15% OF EQUITY INTEREST OF HANGZHOU HEALSUN
BIOPHARMA
AT RMB125 MILLION
    * UPON COMPLETION OF DISPOSAL, CO'S STAKE IN HANGZHOU
HEALSUN
BIOPHARMA WILL BECOME 5.68%
    * ESTIMATED THAT GROUP WILL RECORD A GAIN ON DISPOSAL OF
ABOUT
RMB62.5 MILLION


Further company coverage:  2157.HK 

 ((Reuters.Briefs@thomsonreuters.com;))